Literature DB >> 10997748

Maximal functional capacity in patients with Chagas' cardiomyopathy without congestive heart failure.

C Mady1, B M Ianni, E Arteaga, V M Salemi, C de Carvalho Frimm.   

Abstract

BACKGROUND: Chagas' disease is a known dilated form of cardiomyopathy. However, a great number of patients, although showing electrocardiographic (ECG) well-recognized changes, maintain normal ventricular chamber dimensions and are asymptomatic. The aim of the present study was to objectively characterize functional capacity in asymptomatic patients with Chagas' disease and normal left ventricular function. METHODS AND
RESULTS: Eighteen asymptomatic male patients with Chagas' disease, aged 33+/-6 years, were selected for the study. All showed ECG changes typical of the disease, as well as left ventricular fractional shortening (LVFS) greater than 0.30 on M-mode 2-dimensionally guided echocardiography. Twenty sedentary normal male patients, aged 29+/-6 years, served as controls. Both groups were submitted to ergoespirometry testing for assessment of exercise functional capacity. Patients with Chagas' disease, when compared with controls, showed lower (P < .001) maximal O2 consumption (VO2max, 24.3+/-4.2 v 37.0+/-5.4 mL x kg(-1) x min(-1) respectively); O2 pulse rate (PO2max, 10.5+/-1.4 v 15.1+/-2.5 mL/beat, respectively); maximal ventilation (VEmax, 50.1+/-13.5 v 113.0+/-17.6 L x min(-1), respectively); anaerobic threshold of maximal O2 consumption (VO2-AT, 15.8+/-3.6 v 24.6+/-4.7 mL x kg(-1) x min(-1), respectively); and maximal heart rate (HRmax, 154+/-21 v 186+/-7 beat x min(-1), respectively).
CONCLUSIONS: Asymptomatic patients with Chagas' disease, although presenting normal left ventricular systolic function at rest, display a substantial impairment of exercise functional capacity.

Entities:  

Mesh:

Year:  2000        PMID: 10997748     DOI: 10.1054/jcaf.2000.8828

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  5 in total

1.  Effects of Trypanosoma cruzi infection on myocardial morphology, single cardiomyocyte contractile function and exercise tolerance in rats.

Authors:  Rômulo D Novaes; Arlete R Penitente; Reggiani V Gonçalves; André Talvani; Clóvis A Neves; Izabel R S C Maldonado; Antônio J Natali
Journal:  Int J Exp Pathol       Date:  2011-07-08       Impact factor: 1.925

2.  Capillary damage in skeletal muscle in advanced Chagas' disease patients.

Authors:  Sonia H Torres; Héctor J Finol; María Montes de Oca; Francia Vásquez; Juan J Puigbó; José G Loyo
Journal:  Parasitol Res       Date:  2004-06-15       Impact factor: 2.289

3.  Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy.

Authors:  Henrique S Costa; Marcia Maria O Lima; Pedro Henrique S Figueiredo; Patrícia M Martinelli; Elizabeth Rs Camargos; Ana Thereza Chaves; Maria Carmo Pereira Nunes; Manoel Otavio C Rocha
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-08-20       Impact factor: 2.743

4.  Six-minute walk test and incremental shuttle walk test in the evaluation of functional capacity in Chagas heart disease.

Authors:  Henrique Silveira Costa; Márcia Maria Oliveira Lima; Susan Martins Lage; Fábio Silva Martins da Costa; Pedro Henrique Scheidt Figueiredo; Manoel Otávio da Costa Rocha
Journal:  J Exerc Rehabil       Date:  2018-10-31

5.  Determinants of Functional Capacity in Patients with Chagas Disease.

Authors:  Whesley Tanor Silva; Henrique Silveira Costa; Pedro Henrique Scheidt Figueiredo; Márcia Maria Oliveira Lima; Vanessa Pereira Lima; Fábio Silva Martins da Costa; Matheus Ribeiro Ávila; Vanessa Amaral Mendonça; Ana Cristina Rodrigues Lacerda; Maria Carmo Pereira Nunes; Manoel Otávio Costa Rocha
Journal:  Arq Bras Cardiol       Date:  2021-11       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.